Literature DB >> 32044698

Teleophthalmology for the elderly population: A review of the literature.

Farhad Fatehi1, Farzad Jahedi2, Mei-Ling Tay-Kearney3, Yogesan Kanagasingam4.   

Abstract

BACKGROUND: Ophthalmology is one of the most requested medical speciality services in the elderly population. Although numerous studies have shown the potentials of telemedicine for the provision of ophthalmology services, the extent of its usability in older adults and the aged population is not clear. The aim of this study was to investigate the characteristics and usability features of teleophthalmology for the elderly population.
METHOD: We searched PubMed, Embase, Scopus and CINAHL for relevant studies since 2008. Forty-five papers met the eligibility criteria and included in this review. We used a multifaceted model to extract the data and analyze findings by cross-tabulation.
RESULTS: The majority of the reviewed papers included participants of 65 years of age or older. Most of the studies were conducted in the USA (38 %). Diabetic retinopathy, glaucoma, age-related macular degeneration and cataract were the most researched eye diseases, and among the imaging technologies, retinal photography had been used the most (72 %). The studies showed teleophthalmology can improve access to specialty care, reduce the number of unnecessary visits, alleviate overloads on treatment centers, and provide more comprehensive exams. It also made services cost-saving for stakeholders and cost-effective in rural areas. However, teleophthalmology was not cost-effective for patients above 80 and low-density population areas.
CONCLUSION: Evidence is lacking for the usability and effectiveness of teleophthalmology for the elderly population. The findings suggest that primary care providers in collaboration with ophthalmologists could provide more effective eye care to elderly population. Appropriate training is also necessary for primary care doctors to manage and refer older patients in a timely manner. Diagnostic value and cost-effective imaging modalities which are the core of the teleophthalmology, can be enhanced by image processing techniques and artificial intelligence.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Aged; Elderly; Ocular telemedicine; Telehealth; Teleophthalmology

Year:  2020        PMID: 32044698     DOI: 10.1016/j.ijmedinf.2020.104089

Source DB:  PubMed          Journal:  Int J Med Inform        ISSN: 1386-5056            Impact factor:   4.046


  5 in total

Review 1.  COVID-19: Preliminary Clinical Guidelines for Ophthalmology Practices.

Authors:  Reza Gharebaghi; Jordan Desuatels; Majid Moshirfar; Maryam Parvizi; Seyed-Hashem Daryabari; Fatemeh Heidary
Journal:  Med Hypothesis Discov Innov Ophthalmol       Date:  2020-04-06

2.  Remote assessment in sport and exercise medicine (SEM): a narrative review and teleSEM solutions for and beyond the COVID-19 pandemic.

Authors:  H Paul Dijkstra; Emin Ergen; Louis Holtzhausen; Ian Beasley; Juan Manuel Alonso; Liesel Geertsema; Celeste Geertsema; Sofie Nelis; Aston Seng Huey Ngai; Ivan Stankovic; Stephen Targett; Thor Einar Andersen
Journal:  Br J Sports Med       Date:  2020-06-30       Impact factor: 13.800

3.  Utilization of Remote Diabetic Retinal Screening in a Suburban Healthcare System.

Authors:  Kristen H Kuo; Sidrah Anjum; Brian Nguyen; Jeffrey L Marx; Shiyoung Roh; David J Ramsey
Journal:  Clin Ophthalmol       Date:  2021-09-21

Review 4.  Progress on application of spatial epidemiology in ophthalmology.

Authors:  Cong Li; Kang Chen; Kaibo Yang; Jiaxin Li; Yifan Zhong; Honghua Yu; Yajun Yang; Xiaohong Yang; Lei Liu
Journal:  Front Public Health       Date:  2022-08-10

5.  Protocol for a qualitative study to explore acceptability, barriers and facilitators of the implementation of new teleophthalmology technologies between community optometry practices and hospital eye services.

Authors:  Ann Blandford; Sarah Abdi; Angela Aristidou; Josie Carmichael; Giulia Cappellaro; Rima Hussain; Konstantinos Balaskas
Journal:  BMJ Open       Date:  2022-07-20       Impact factor: 3.006

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.